Shin’ichi Takeda

Success of 'exon-skipping' strategy in dogs bodes well for treatment of human DMD

posted on March 17, 2009 - 9:00pm
Scientists at Children's National Medical Center in Washington, Carolinas Medical Center in Charlotte, N.C., and the National Center of Neurology and Psychiatry in Tokyo, have successfully treated dogs with a disease closely resembling Duchenne muscular dystrophy (DMD) , using a molecular treatment strategy called "exon skipping." The strategy is simultaneously under development in human patients.

New content is being added every day. Please check back again.